Purpose: Compelling evidence has unveiled the importance of long noncoding RNAs (lncRNAs) in malignant behavior of Wilms’ tumor (WT). Hereon, we intend to assess the function and associated molecular mechanism of lncRNA maternally expressed gene 8 (MEG8) in WT cells. Methods: Expression levels of MEG8, miR-23a-3p, and CT10 regulator of kinase (CRK) were determined by quantitative real-time polymerase chain reaction. Cell viability was assessed by MTT assay. Besides, wound healing assay and transwell assay were applied to examine abilities of cell migration and invasion, respectively. Dual-luciferase reporter assay was employed to test the interplay among MEG8, miR-23a-3p, and CRK. Western blot was used to detect relative protein expression of CRK. Results: MEG8 and CRK expression was elevated, while miR-23a-3p expression was decreased in WT tissues and cells. The histologic type, lymphatic metastasis, and National Wilms Tumor Study (NWTS) stage were associated with the expression of MEG8, miR-23a-3p, and CRK in WT patients. MEG8 knockdown or miR-23a-3p overexpression restrained WT cells in cell viability, migration, and invasiveness in vitro. As to mechanism exploration, MEG8 could directly bind to miR-23a-3p and then miR-23a-3p targeted CRK. MEG8 was inversely correlated with miR-23a-3p and positively correlated with CRK in WT tissues. Meantime, miR-23a-3p was inversely correlated with CRK in WT tissues. Additionally, MEG8 knockdown-mediated suppressive impacts on cell viability, migration, and invasiveness were reversed by overexpression of CRK or repression of miR-23a-3p in WT cells. Conclusions: The cell viability, migration, and invasiveness of WT cells were repressed by MEG8 knockdown via targeting the miR-23a-3p/CRK axis.

1.
Breslow
NE
,
Beckwith
JB
,
Perlman
EJ
,
Reeve
AE
.
Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor
.
Pediatr Blood Cancer
.
2006
;
47
:
260
7
. .
2.
Aldrink
JH
,
Heaton
TE
,
Dasgupta
R
,
Lautz
TB
,
Malek
MM
,
Abdessalam
SF
,
Update on Wilms tumor
.
J Pediatr Surg
.
2019
;
54
:
390
7
. .
3.
Murphy
AJ
,
Davidoff
AM
.
Bilateral Wilms tumor: a surgical perspective
.
Children
.
2018
;
5
:
134
. .
4.
John
R
,
Kurian
JJ
,
Sen
S
,
Gupta
MK
,
Jehangir
S
,
Mathew
LG
,
Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India
.
J Pediatr Urol
.
2018
;
14
:
547.e1
e7
. .
5.
Al-Hussain
T
,
Ali
A
,
Akhtar
M
.
Wilms tumor: an update
.
Adv Anat Pathol
.
2014
;
21
:
166
73
. .
6.
Maschietto
M
,
Piccoli
FS
,
Costa
CM
,
Camargo
LP
,
Neves
JI
,
Grundy
PE
,
Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour
.
Eur J Cancer
.
2011
;
47
:
2715
22
. .
7.
Liu
G
,
Zhang
Y
,
Fu
K
,
Hu
J
,
Zhao
Z
,
Fu
W
,
Meta-analysis of the effect of preoperative chemotherapy on Wilms’ tumor
.
J BUON
.
2018
;
23
:
211
7
.
8.
Oostveen
RM
,
Pritchard-Jones
K
.
Pharmacotherapeutic management of Wilms tumor: an update
.
Paediatr Drugs
.
2019
;
21
:
1
13
. .
9.
Phelps
HM
,
Kaviany
S
,
Borinstein
SC
,
Lovvorn
HN
 3rd
.
Biological drivers of Wilms tumor prognosis and treatment
.
Children
.
2018
;
5
. .
10.
Xing
YH
,
Bai
Z
,
Liu
CX
,
Hu
SB
,
Ruan
M
,
Chen
LL
.
Research progress of long noncoding RNA in China
.
IUBMB Life
.
2016
;
68
:
887
93
. .
11.
Cui
WW
,
Sun
YL
,
Chen
C
,
Feng
RR
,
Xu
W
,
Meng
JJ
,
LncRNA CRNDE promotes the development of Wilms’ tumor by regulating microRNA-424
.
Eur Rev Med Pharmacol Sci
.
2020
;
24
:
1088
97
. .
12.
Zhu
KR
,
Sun
QF
,
Zhang
YQ
.
Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway
.
Eur Rev Med Pharmacol Sci
.
2019
;
23
:
5691
8
. .
13.
Zhao
XS
,
Tao
N
,
Zhang
C
,
Gong
CM
,
Dong
CY
.
Long noncoding RNA MIAT acts as an oncogene in Wilms’ tumor through regulation of DGCR8
.
Eur Rev Med Pharmacol Sci
.
2019
;
23
:
10257
63
. .
14.
Liu
Y
,
Li
L
,
Shang
P
,
Song
X
.
LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis
.
Anticancer Drugs
.
2020
;
31
:
1065
73
. .
15.
Lou
J
,
Yan
W
,
Li
QY
,
Zhu
AK
,
Tan
BQ
,
Dong
R
,
LncRNA MEG8 plays an oncogenic role in hepatocellular carcinoma progression through miR-367-3p/14-3-3zeta/TGFbetaR1 axis
.
Neoplasma
.
2020
.
16.
Paraskevopoulou
MD
,
Hatzigeorgiou
AG
.
Analyzing MiRNA-LncRNA interactions
.
Methods Mol Biol
.
2016
;
1402
:
271
86
. .
17.
Zhang
G
,
Pian
C
,
Chen
Z
,
Zhang
J
,
Xu
M
,
Zhang
L
,
Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network
.
PLoS One
.
2018
;
13
:
e0196681
. .
18.
Bartel
DP
.
MicroRNAs: target recognition and regulatory functions
.
Cell
.
2009
;
136
:
215
33
. .
19.
Bartel
DP
.
MicroRNAs: genomics, biogenesis, mechanism, and function
.
Cell
.
2004
;
116
:
281
97
. .
20.
Bao
JW
,
Li
WJ
,
Guo
JH
,
Lv
ZB
,
Whang
Z
.
MiRNA-203a-5p alleviates the malignant progression of Wilms’ tumor via targeting JAG1
.
Eur Rev Med Pharmacol Sci
.
2020
;
24
:
5329
35
. .
21.
Wang
HF
,
Zhang
YY
,
Zhuang
HW
,
Xu
M
.
MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms’ tumor via targeting FRS2
.
Eur Rev Med Pharmacol Sci
.
2017
;
21
:
3360
9
.
22.
Che
G
,
Gao
H
,
Tian
J
,
Hu
Q
,
Xie
H
,
Zhang
Y
.
MicroRNA-483-3p promotes proliferation, migration, and invasion and induces chemoresistance of Wilms’ tumor cells
.
Pediatr Dev Pathol
.
2020
;
23
:
144
51
. .
23.
Koller
K
,
Das
S
,
Leuschner
I
,
Korbelius
M
,
Hoefler
G
,
Guertl
B
.
Identification of the transcription factor HOXB4 as a novel target of miR-23a
.
Genes Chromosomes Cancer
.
2013
;
52
:
709
15
. .
24.
Liu
J
,
Chen
M
,
Ma
L
,
Dang
X
,
Du
G
.
LncRNA GAS5 suppresses the proliferation and invasion of osteosarcoma cells via the miR-23a-3p/PTEN/PI3K/AKT pathway
.
Cell Transplant
.
2020
;
29
:
963689720953093
. .
25.
Ding
F
,
Lai
J
,
Gao
Y
,
Wang
G
,
Shang
J
,
Zhang
D
,
NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression
.
Cancer Cell Int
.
2019
;
19
:
217
. .
26.
Zheng
H
,
Li
BH
,
Liu
C
,
Jia
L
,
Liu
FT
.
Comprehensive analysis of lncRNA-mediated ceRNA crosstalk and identification of prognostic biomarkers in Wilms’ tumor
.
Biomed Res Int
.
2020
;
2020
:
4951692
. .
27.
Wang
X
,
Gao
X
,
Tian
J
,
Zhang
R
,
Qiao
Y
,
Hua
X
,
LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p
.
Arch Biochem Biophys
.
2020
;
689
:
108469
. .
28.
Martinez
CH
,
Dave
S
,
Izawa
J
.
Wilms’ tumor
.
Adv Exp Med Biol
.
2010
;
685
:
196
209
.
29.
Abbo
O
,
Pinnagoda
K
,
Brouchet
L
,
Leobon
B
,
Savagner
F
,
Oliver
I
,
Wilms tumor, pleuropulmonary blastoma, and DICER1: case report and literature review
.
World J Surg Oncol
.
2018
;
16
:
164
. .
30.
Zhang
J
,
Hou
T
,
Qi
X
,
Wang
J
,
Sun
X
.
SOX21-AS1 is associated with clinical stage and regulates cell proliferation in nephroblastoma
.
Biosci Rep
.
2019
;
39
. .
31.
Zhu
S
,
Fu
W
,
Zhang
L
,
Fu
K
,
Hu
J
,
Jia
W
,
LINC00473 antagonizes the tumour suppressor miR-195 to mediate the pathogenesis of Wilms tumour via IKKα
.
Cell Prolif
.
2018
;
51
:
51
. .
32.
Yoon
JH
,
Abdelmohsen
K
,
Gorospe
M
.
Functional interactions among microRNAs and long noncoding RNAs
.
Semin Cell Dev Biol
.
2014
;
34
:
9
14
. .
33.
Staedel
C
,
Tran
TPA
,
Giraud
J
,
Darfeuille
F
,
Di Giorgio
A
,
Tourasse
NJ
,
Modulation of oncogenic miRNA biogenesis using functionalized polyamines
.
Sci Rep
.
2018
;
8
:
1667
. .
34.
Mayer
BJ
,
Hamaguchi
M
,
Hanafusa
H
.
A novel viral oncogene with structural similarity to phospholipase C
.
Nature
.
1988
;
332
:
272
5
. .
35.
Nishihara
H
,
Tanaka
S
,
Tsuda
M
,
Oikawa
S
,
Maeda
M
,
Shimizu
M
,
Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers
.
Cancer Lett
.
2002
;
180
:
55
61
. .
36.
Miller
CT
,
Chen
G
,
Gharib
TG
,
Wang
H
,
Thomas
DG
,
Misek
DE
,
Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas
.
Oncogene
.
2003
;
22
:
7950
7
. .
37.
Takino
T
,
Nakada
M
,
Miyamori
H
,
Yamashita
J
,
Yamada
KM
,
Sato
H
.
CrkI adapter protein modulates cell migration and invasion in glioblastoma
.
Cancer Res
.
2003
;
63
:
2335
7
.
38.
Liu
H
,
Ren
SY
,
Qu
Y
,
Liu
C
,
Zhang
Y
,
Li
XQ
,
MiR-194-5p inhibited metastasis and EMT of nephroblastoma cells through targeting Crk
.
Kaohsiung J Med Sci
.
2020
;
36
:
265
73
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.